Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease
PaperCitations, authors & open-access status
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 132 citations, 2011 year and diamond oa status.
132
Citations
2011
Year
diamond
OA Status